Ovarian morphological changes with injectable contraceptives and their relation to cycle control.
Yassin
S
S
El-mahgoub
S
S
Ammar
R
R
Karim
M
M
D000568:Amenorrhea; D001695:Biology; D003267:Contraception; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003338:Corpus Luteum; D004194:Disease; D004717:Endometrium; D005193:Family Planning Services; D005835:Genitalia; D005836:Genitalia, Female; D006653:Histology; D007267:Injections; D017258:Medroxyprogesterone Acetate; D008597:Menstrual Cycle; D008599:Menstruation Disturbances; D009640:Norethindrone; D010053:Ovary; D010060:Ovulation; D010827:Physiology; D012106:Research; D014566:Urogenital System; D014599:Uterus; D014621:Vagina; D014627:Vaginitis
D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D017258:Medroxyprogesterone Acetate; D009640:Norethindrone
Amenorrhea; Biology; Clinical Research; Contraception; Contraceptive Agents, Female--therapeutic use; Contraceptive Agents, Progestin--therapeutic use; Contraceptive Agents--therapeutic use; Corpus Luteum; Diseases; Endometrial Effects; Endometrium; Family Planning; Genitalia; Genitalia, Female; Histology; Injectables; Medroxyprogesterone Acetate--therapeutic use; Menstrual Cycle; Menstruation Disorders; Norethindrone--therapeutic use; Ovarian Effects; Ovary; Ovulation Suppression; Physiology; Research Methodology; Urogenital System; Uterus; Vaginal Abnormalities; Vaginal Desquamate Effects; Vaginitis